This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (36)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Follow-up of The Kroc Collaborative Study

The Kroc Collaborative Study Group

JAMA. 1988;260(1):37-41.

Abstract
The progression of retinopathy was reevaluated at two years in 64 of the 68 patients with mild to moderate diabetic retinopathy, originally randomly assigned for an eight-month period either to intensified diabetic control with continuous subcutaneous insulin infusion (CSII) or to unchanged conventional injection treatment. Twenty-three of the 34 patients in the former group and 24 of the 34 in the latter agreed to continue to follow their original treatment assignment for a further 16 months. The others crossed over at the end of the first eight months of the study. During those first eight months, substantial lowering of blood glucose concentration had been achieved in the CSII group, unexpectedly associated with evidence of accelerated progression of retinopathy compared with the conventional injection treatment group. Glycemic separation was maintained at two years between the two groups continuing to receive the assigned treatment; during this time the mean retinopathy level deteriorated with conventional injection treatment and improved with CSII. At two years the degree of retinopathy in the two treatment groups was indistinguishable, with some trend to lesser overall deterioration with CSII. It is concluded that, in diabetics with mild to moderate nonproliferative retinopathy, the acceleration in activity associated with tightened control is not sustained and does not initiate vasoproliferative deterioration in retinopathy.

(JAMA 1988;260:37-41)

Author Affiliations
From The Kroc Collaborative Study Group.

Footnotes
Reprint requests to the Department of Internal Medicine, Yale University School of Medicine, 333 Cedar St, New Haven, CT 06510 (Robert S. Sherwin, MD).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Management of Diabetic Retinopathy: A Systematic Review
Mohamed et al.
JAMA 2007;298:902-916.
ABSTRACT | FULL TEXT  

Effect of tranilast in early-stage diabetic nephropathy
Soma et al.
Nephrol Dial Transplant 2006;21:2795-2799.
ABSTRACT | FULL TEXT  

Screening for Retinopathy in the Pediatric Patient With Type 1 Diabetes Mellitus
Lueder et al.
Pediatrics 2005;116:270-273.
ABSTRACT | FULL TEXT  

Progression of Retinopathy in Insulin-Treated Type 2 Diabetic Patients
Henricsson et al.
Diabetes Care 2002;25:381-385.
ABSTRACT | FULL TEXT  

High Prevalence and Adverse Effect of Hepatitis C Virus Infection in Type II Diabetic-Related Nephropathy
SOMA et al.
J. Am. Soc. Nephrol. 2000;11:690-699.
ABSTRACT | FULL TEXT  

Insulin-Induced Vascular Endothelial Growth Factor Expression in Retina
Lu et al.
IOVS 1999;40:3281-3286.
ABSTRACT | FULL TEXT  

Treatment of Diabetic Retinopathy
Ferris et al.
NEJM 1999;341:667-678.
FULL TEXT  

Early Worsening of Diabetic Retinopathy in the Diabetes Control and Complications Trial
The Diabetes Control and Complications Trial Resea
Arch Ophthalmol 1998;116:874-886.
ABSTRACT | FULL TEXT  

Evidence that upregulation of serum IGF-1 concentration can trigger acceleration of diabetic retinopathy
Chantelau
Br J Ophthalmol 1998;82:725-730.
ABSTRACT | FULL TEXT  

Screening for Retinopathy in the Pediatric Patient With Type 1 Diabetes Mellitus
Sections on Endocrinology and Ophthalmology
Pediatrics 1998;101:313-314.
FULL TEXT  

Outcomes of Patients With Hypertension and Non--insulin-dependentn Diabetes Mellitus Treated by Different Systems and Specialties: Results From the Medical Outcomes Study
Greenfield et al.
JAMA 1995;274:1436-1444.
ABSTRACT  

Relationship of Hyperglycemia to the Long-term Incidence and Progression of Diabetic Retinopathy
Klein et al.
Arch Intern Med 1994;154:2169-2178.
ABSTRACT  

Diseases of the Retina
D'Amico
NEJM 1994;331:95-106.
FULL TEXT  

The Effect of Long-Term Intensified Insulin Treatment on the Development of Microvascular Complications of Diabetes Mellitus
Reichard et al.
NEJM 1993;329:304-309.
ABSTRACT | FULL TEXT  

The Treatment of Diabetic Retinopathy: A View for the Internist
Raskin and Arauz-Pacheco
ANN INTERN MED 1992;117:226-233.
ABSTRACT  

Aldose Reductase Inhibition: The Chemical Key to the Control of Diabetic Retinopathy?
Frank
Arch Ophthalmol 1990;108:1229-1231.
ABSTRACT  

The Diabetes Control and Complications Trial (DCCT): The Trial Coordinator Perspective: Report by the DCCT Research Group
Annahern et al.
The Diabetes Educator 1989;15:236-241.
 

Glycosylated Hemoglobin Predicts the Incidence and Progression of Diabetic Retinopathy
Klein et al.
JAMA 1988;260:2864-2871.
ABSTRACT  

INTENSIVE INSULIN TREATMENT DOES NOT PROMOTE RETINOPATHY
JWatch General 1988;1988:2-2.
FULL TEXT